Discovery Life Sciences

March marks #WomensHistoryMonth! From human resources and accounting to quality assurance and pathology, women play a vital role in our science community. Swipe to see how Discovery’s very own Annette Mühleisen and Mandy Andrade contribute to pushing the world of science forward!

Oncology biospecimens + precision biomarker services — under one roof. See us at #AACR26, booth #3038 → San Diego, April 17–22 Book time with our team: lnkd.in/e2sVExFC

How do IVDR regulations impact clinical trial assay development? Join Discovery's Scott Reid, VP & Global Head of Companion Diagnostic Services during his presentation at World CB & CDx Summit EU on Tuesday, 31 March at 5:20 Connect with our experts: lnkd.in/egfs3rRv

March marks #WomensHistoryMonth! From human resources and accounting to quality assurance and pathology, women play a vital role in our science community. Swipe to see how Discovery’s very own Tamara Bowles and Mimi Lo contribute to pushing the world of science forward!

Autoimmune research doesn’t follow a standard playbook. Read how Discovery supports autoimmune research. lnkd.in/eXT7-cM8

Limited seats. Limitless impact. Join Discovery on the B4 Tour, an in-person 3-city series exploring innovations in genomics, proteomics, molecular pathology, & cell biology powering precision medicine. Register today. lnkd.in/eW2qhen4

New app note: 3D hepatocyte spheroids deliver longer-lived, human-relevant metabolism for low-clearance drug compounds. Explore our workflow + performance data: lnkd.in/euXM7qgt

We're heading to #WorldCBCDx in London (30 Mar – 1 Apr). Our team is ready to talk specialty biomarker lab services, CDx development, and how our EU Health Institution status simplifies IVDR for clinical trials. Schedule a meeting with the team: lnkd.in/egfs3rRv

Discovery is excited to attend the 2026 Bionow Precision Medicine Conference, 23 March in Leeds. Catch our program feature presented by Dr. Donald Skifter, Senior Vice President, Scientific Affairs. Schedule a meeting: lnkd.in/gHhbbBG3

Welcoming the Year of the Horse— a symbol of determination, resilience, and forward movement. Here’s to a year of meaningful progress, bold ideas, and scientific discovery. Happy Chinese New Year!

This #BlackHistoryMonth, we honor Black scientists whose breakthroughs shaped modern medicine. From blood banking to genetics, immunology, and vaccine innovation, we celebrate their legacy and remain committed to a more inclusive future in science.

Take your preclinical testing to the 3rd dimension with 3D liver models. Watch our video to see how hepatocyte spheroids support ADME research, novel therapies, and understand key parameters for success: lnkd.in/gdH-HacZ

This #WorldCancerDay, we honor everyone impacted by cancer and reaffirm our commitment to advancing precision oncology. At Discovery, we power cancer research with high-quality biospecimens that enhance therapeutic discovery.

Biomarker-driven studies often stall early on because researchers can’t easily source biospecimens with confirmed genetic variants. Discovery’s SpecimenSeq removes this barrier.  Watch this video to learn more - lnkd.in/eayKVTqz.

As the year comes to a close, we want to thank our partners, team, and community that drive our work forward. From all of us at Discovery, Happy Holidays!

ICYMI: Dr. Shawn Fahl and Meredith Osborn explain why traditional tumor models fall short and how co-culturing tumoroids with immune cells and CAFs creates a more realistic tumor microenvironment. See how relevant patient tumoroids strengthen discovery: lnkd.in/giFCWSZG

Interested in how DTCs support ovarian cancer profiling and single-cell long-read sequencing? Watch our new “Between Two Hoods” video as our experts discuss two recent publications and their impact on emerging research. youtu.be/TUUrk_sNP3U

@EliLillyandCo announced a $6B investment to build next-gen API manufacturing facility outside of Huntsville, AL. Construction begins 2026 with an estimated completion in 2032. A major boost for North Alabama’s growing biotech and biopharma ecosystem.

ADC development often faces inconsistent target expression, unclear mechanisms, and off-tumor toxicity. Our updated ADC brochure highlights how Discovery's IHC, multi-omics, and toxicity platforms help teams move next-gen programs forward with clarity. lnkd.in/gcmEUKjF

On #WorldAIDSDay, Discovery honors those affected by HIV and supports research driving progress. Study findings using our CD4+ T cells revealed a new HIV entry pathway and therapeutic target. lnkd.in/geu-xKM6 #HIVResearch #GlobalHealth